/CNW/ - Today, AstraZeneca and Amgen announced the Canadian availability of Tezspire™ (tezepelumab injection), indicated for the add-on maintenance treatment.
/CNW/ - Today, AstraZeneca announced the Canadian availability of Breztri™ Aerosphere® (budesonide/glycopyrronium/formoterol fumarate dihydrate), indicated for.
/CNW/ - AstraZeneca s Evusheld™ (tixagevimab and cilgavimab), a long-acting antibody combination has received a Notice of Compliance from Health Canada for the.
/CNW/ - AstraZeneca Canada, a leading innovation-driven biopharmaceutical company, is proud to announce that it received The Venngo Award for Best Workplace.